Novavax's COVID vaccine brought in sales of $38.21 million ... that Donald Trump as U.S. president will be a boon for ...

Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript ... The trial will enroll adults aged 65 years and older and is ...

But what about vaccines from Moderna and Novavax? Here's what we know. Australia's medicines watchdog has approved Pfizer's new COVID-19 vaccine and it's set to be available in the coming months.

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

The findings were based on blood samples collected from 50 COVID-19 patients in Australia collected up to 18 months after ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

Donald Trump's nomination of Robert F Kennedy Jr. to lead the Department of Health and Human Services sent shares of major ...

The approval of Novavax' COVID-19 vaccine in Great Britain ... Health Organisation (WHO), as well as other countries including Australia, New Zealand, South Korea, India and Indonesia.

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe disease. But last month, the state of Florida issued updated vaccine guidance ...

China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...

Opus IVStm, the global leader in intelligent vehicle support, is excited to unveil IVS Mobile, an advanced mobile diagnostic app designed to deliver OEM-level diagnostics and expert support for ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza ... with Chemist Warehouse approved Australia's Sigma Healthcare's top ...